CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Diaxonhit SA Company Snapshot
Diaxonhit SA operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Diaxonhit SA with three other pharmaceutical manufacturers in Europe: Biofarm SA of Romania (2017 sales of 170.23 million Romanian Leu [US$45.48 million] ), Santhera Pharmaceuticals Holding AG of Switzerland (22.90 million Swiss Francs [US$24.65 million] ), and Orexo Ab which is based in Sweden (643.70 million Swedish Kronor [US$80.91 million] ).

Sales Analysis. During the year ended December of 2017, sales at Diaxonhit SA were 42.90 million Euro (US$53.42 million). This is an increase of 54.8% versus 2016, when the company's sales were 27.72 million Euro.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Diaxonhit SA
  Stock Performance Chart for Diaxonhit SA
 
  Stock Data: Recent Stock Performance:
  Current Price (2/9/2018): 4.49
(Figures in Euro)
1 Week -2.9%   13 Weeks -6.6%  
4 Weeks -3.4%   52 Weeks -2.4%  
 
Diaxonhit SA Key Data:
  Ticker: ALEHT Country: France
  Exchanges: PAR Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 42,900,000
(Year Ending Jan 2018).
Employees: 76
  Currency: Euro Market Cap: 42,390,658
  Fiscal Yr Ends: December Shares Outstanding: 9,441,127
  Share Type: Action Ordinaires Closely Held Shares:
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.